Mucosal and systemic immune responses to Mycobacterium tuberculosis antigen 85A following its co-delivery with CpG, MPLA or LTB to the lungs in mice
about
Effect of vaccine administration modality on immunogenicity and efficacy.Identification of an ideal adjuvant for receptor-binding domain-based subunit vaccines against Middle East respiratory syndrome coronavirus.Mucosal delivery switches the response to an adjuvanted tuberculosis vaccine from systemic TH1 to tissue-resident TH17 responses without impacting the protective efficacy.Novel adjuvant formulations for delivery of anti-tuberculosis vaccine candidatesIntravaginal immunisation using a novel antigen-releasing ring device elicits robust vaccine antigen-specific systemic and mucosal humoral immune responses.Devices and formulations for pulmonary vaccination.Development of a new tuberculosis vaccine: is there value in the mucosal approach?Dry influenza vaccines: towards a stable, effective and convenient alternative to conventional parenteral influenza vaccination.Recent advances in nontoxic Escherichia coli heat-labile toxin and its derivative adjuvants.Artificial bacterial biomimetic nanoparticles synergize pathogen-associated molecular patterns for vaccine efficacy.Recombinant Invasive Lactococcus lactis Carrying a DNA Vaccine Coding the Ag85A Antigen Increases INF-γ, IL-6, and TNF-α Cytokines after Intranasal Immunization.Lipid-Based Particles: Versatile Delivery Systems for Mucosal Vaccination against Infection.A Strong Humoral Immune Response Induced by a Vaccine Formulation Containing rSm29 Adsorbed to Alum Is Associated With Protection Against Reinfection in Mice
P2860
Q27692376-9603BC23-82B3-47DE-B97A-21A8BE84CE1DQ30371303-277E6015-59F2-45A9-A3DE-C6B04CA6C9CEQ36372507-965D18B6-690F-49E1-8029-AD9F5EA4F78CQ36909492-A69E49C5-1864-4692-A9B6-D3EBF9465C60Q37677269-E6F32078-B737-45DB-B893-2FF8B52A3BFBQ38115814-CCF12287-F340-4216-8E8E-332D86215E87Q38262258-440CA9AA-6D44-4F23-90F8-42DC046D1641Q38818697-92C96AB9-4299-41D4-907D-E56AD23A714FQ38818721-0597C252-1A9C-41B0-8F6A-FD765758070FQ39780595-A208A604-553D-4AC6-A742-9BA64374C43CQ40974795-708F2E3A-9F1C-4B0C-B394-C40B3FDEE8D7Q52725104-2C5BE094-FFED-42F7-BB22-C21AFE444F15Q59137480-A21ECF4B-3029-4D5D-B3D8-F971E3ABAD60
P2860
Mucosal and systemic immune responses to Mycobacterium tuberculosis antigen 85A following its co-delivery with CpG, MPLA or LTB to the lungs in mice
description
2013 nî lūn-bûn
@nan
2013 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Mucosal and systemic immune re ...... LA or LTB to the lungs in mice
@ast
Mucosal and systemic immune re ...... LA or LTB to the lungs in mice
@en
Mucosal and systemic immune re ...... LA or LTB to the lungs in mice
@nl
type
label
Mucosal and systemic immune re ...... LA or LTB to the lungs in mice
@ast
Mucosal and systemic immune re ...... LA or LTB to the lungs in mice
@en
Mucosal and systemic immune re ...... LA or LTB to the lungs in mice
@nl
prefLabel
Mucosal and systemic immune re ...... LA or LTB to the lungs in mice
@ast
Mucosal and systemic immune re ...... LA or LTB to the lungs in mice
@en
Mucosal and systemic immune re ...... LA or LTB to the lungs in mice
@nl
P2093
P2860
P1433
P1476
Mucosal and systemic immune re ...... LA or LTB to the lungs in mice
@en
P2093
Catherine Fillee
Fabienne Jurion
Julie Todoroff
Muriel M Lemaire
Rita Vanbever
P2860
P304
P356
10.1371/JOURNAL.PONE.0063344
P407
P577
2013-05-10T00:00:00Z